Lac-hydrin and Ketoconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lac-hydrin (ammonium lactate) and Ketoconazole (ketoconazole). Common drug interactions include abdominal discomfort among females and agitation among males.

The phase IV clinical study analyzes what interactions people have when they take Lac-hydrin and Ketoconazole. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Lac-hydrin?

Lac-hydrin has active ingredients of ammonium lactate. eHealthMe is studying from 534 Lac-hydrin users. Check the latest studies of Lac-hydrin.

What is Ketoconazole?

Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 16,014 Ketoconazole users. Check the latest studies of Ketoconazole.



On Jul, 16, 2026

13 people who take Lac-hydrin and Ketoconazole together, and have interactions are studied.

Lac-hydrin and Ketoconazole drug interactions.

What are the common drug interactions of Lac-Hydrin and Ketoconazole, by gender? *:

female:

  1. Abdominal discomfort
  2. Blood glucose increased
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Dehydration (dryness resulting from the removal of water)
  6. Dizziness
  7. Drug ineffective
  8. Dyspnoea (difficult or laboured respiration)
  9. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  10. Hypertension (high blood pressure)

male:

  1. Agitation (state of anxiety or nervous excitement)
  2. Confusion
  3. Renal failure (kidney dysfunction)
  4. Lymphocyte count decreased
  5. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  6. Chronic kidney disease
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Immunosuppressant drug level increased
  9. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Lac-Hydrin and Ketoconazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Weight increased

30-39:

n/a

40-49:

  1. Agitation (state of anxiety or nervous excitement)
  2. Confusion
  3. Lymphocyte count decreased
  4. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  5. Chronic kidney disease
  6. Hypertension (high blood pressure)
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Neutrophilia
  9. Renal failure (kidney dysfunction)

50-59:

  1. Blood glucose increased
  2. Headache (pain in head)
  3. Hypertension (high blood pressure)

60+:

  1. Abdominal discomfort
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Renal failure (kidney dysfunction)
  4. Soft tissue haemorrhage (bleeding soft tissue)
  5. Urinary retention (the inability to completely or partially empty the bladder)
  6. Urinary tract infection
  7. Waist circumference increased
  8. Anxiety
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Back pain

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 30.77%
  2. Pain: 3 people, 23.08%
  3. Lymphoedema (localized fluid retention and tissue swelling): 2 people, 15.38%
  4. Neuralgia (pain in one or more nerves): 2 people, 15.38%
  5. Constipation: 2 people, 15.38%
  6. Depression: 2 people, 15.38%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 15.38%
  8. Itching: 2 people, 15.38%
  9. Multiple Myeloma (cancer of the plasma cells): 2 people, 15.38%
  10. Nausea (feeling of having an urge to vomit): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Lac-hydrin and Ketoconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lac-hydrin and Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lac-hydrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lac-hydrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ketoconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ammonium lactate and ketoconazole (the active ingredients of Lac-hydrin and Ketoconazole, respectively), and Lac-hydrin and Ketoconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: